PRESS RELEASE published on 12/05/2023 at 15:00, 2 years 4 months ago Cytonus Secures Series A Financing to Advance Pipeline of Novel Cargocyte(TM)-Based Medicines Cytonus Therapeutics, Inc. secures $11.7 million Series A funding led by Partners Investment with a group of new investors to advance its pipeline of novel medicines enabled by its proprietary Cargocyte™ Drug Delivery Platform. The funds will be used for portfolio development targeting metastatic tumors and the central nervous system (CNS) Biotechnology Cytonus Therapeutics Series A Financing Cargocyte Drug Delivery Platform Precision Medicine
Published on 04/09/2026 at 19:15, 54 minutes ago Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Published on 04/09/2026 at 16:00, 4 hours 9 minutes ago Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 5 hours 29 minutes ago Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 6 hours 9 minutes ago Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 6 hours 39 minutes ago Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 18:15, 1 hour 54 minutes ago REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:40, 4 hours 29 minutes ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 4 hours 30 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 18:35, 1 hour 34 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 15:57, 4 hours 12 minutes ago Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 13 hours 9 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 1 day 2 hours ago Publication of the 2025 Universal Registration Document